The Non-Sterile Compounding Pharmacy Market Growth is driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Patients with long-term conditions often require individualized therapies not available through mass production, fueling demand for compounded drugs. Growth is further supported by expanding awareness of bioidentical hormone therapy and dermatological solutions. With the healthcare industry’s growing focus on patient adherence, compounding pharmacies are well positioned to sustain double-digit growth across multiple therapeutic areas.